"10.1371_journal.pone.0125341","plos one","2015-04-27T00:00:00Z","Andrie Koutsoulidou; Tassos C Kyriakides; George K Papadimas; Yiolanda Christou; Evangelia Kararizou; Eleni Zamba Papanicolaou; Leonidas A Phylactou","Department of Molecular Genetics, Function & Therapy, Cyprus Institute of Neurology & Genetics, P.O. Box 2346, 1683 Nicosia, Cyprus; Yale Center for Analytical Sciences,Yale School of Public Health, 300 George Street, Suite 555, New Haven, CT 06520, United States of America; Department of Neurology, Eginitio hospital, Medical School of Athens, 74 Vasilissis Sofias, 11528, Athens, Greece; Neurology Clinic D, Cyprus Institute of Neurology & Genetics, P.O. Box 2346, 1683 Nicosia, Cyprus","Conceived and designed the experiments: LAP. Performed the experiments: AK. Analyzed the data: AK TCK. Contributed reagents/materials/analysis tools: TCK GKP YC EK EZP. Wrote the paper: AK LAP.","L.A.P. and A.K. have led a PCT patent application on ‘MiRNA Biomarkers for Myotonic Dystrophy and Methods of Use Thereof’ (PCT/US2013/047934). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Andrie Koutsoulidou","AK",7,TRUE,1,1,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
